The Scripps Research Institute (TSRI) is a biomedical research corporation established in La Jolla, California with another site in Jupiter, Florida. Its origins stem from a large endowment from ...

These insights could drive the development of new drugs to treat transthyretin amyloidosis, a progressive and fatal disease.

The modern era of climate change research began at Scripps Institution of Oceanography and today Scripps is a global leader in observing how our planet is changing, understanding impacts, finding ...

The tiny protein known as transthyretin can cause big problems in the body when it misfolds after secretion. While healthy transthyretin moves hormones through blood and spinal fluid, misfolded ...

A discovery from The Scripps Research Institute in California may offer more insight than ever before, with claims a chemical process of phosphorylation could have been key. Phosphorylation is ...

The California-based Scripps Research Institute will extend its presence to the East Coast by opening a new annex in Palm Beach, Florida. An exact location has yet to be announced for the planned ...

KULR Technology Group shares were 10% higher, at $2.64, after the company entered into a collaboration with the Scripps Research Institute's Baran Lab to continue development of a pyrolytic carbon ...

Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will ...

has announced an innovative collaboration with the prestigious Scripps Research Institute's Baran Lab. Together, the teams have developed a groundbreaking pyrolytic carbon (PC) electrode material ...

Affordable and Scalable: The pyrolytic carbon electrodes are produced using a proprietary chemical vapor deposition (CVD) process, significantly reducing manufacturing costs and making large-scale ...

KULR Technology and Scripps Research Institute's Baran Lab develop a groundbreaking pyrolytic carbon electrode.

Scientists discovered that repetitive HIV vaccinations can lead the body to produce antibodies targeting the immune complexes ...